Waterloo Capital L.P. Has $573,000 Holdings in McKesson Corporation $MCK

Waterloo Capital L.P. increased its position in shares of McKesson Corporation (NYSE:MCK) by 40.6% during the 2nd quarter, Holdings Channel reports. The fund owned 782 shares of the company’s stock after buying an additional 226 shares during the quarter. Waterloo Capital L.P.’s holdings in McKesson were worth $573,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the company. Nuveen LLC acquired a new stake in McKesson during the 1st quarter worth approximately $475,235,000. Wellington Management Group LLP grew its position in McKesson by 4,559.6% in the first quarter. Wellington Management Group LLP now owns 427,703 shares of the company’s stock valued at $287,840,000 after purchasing an additional 418,524 shares in the last quarter. Boston Partners increased its position in shares of McKesson by 33.3% in the first quarter. Boston Partners now owns 1,461,785 shares of the company’s stock valued at $984,927,000 after acquiring an additional 365,484 shares during the last quarter. Voya Investment Management LLC raised its stake in shares of McKesson by 92.3% during the 1st quarter. Voya Investment Management LLC now owns 650,851 shares of the company’s stock worth $437,760,000 after purchasing an additional 312,473 shares in the last quarter. Finally, Acadian Asset Management LLC boosted its holdings in shares of McKesson by 68.0% in the 2nd quarter. Acadian Asset Management LLC now owns 636,596 shares of the company’s stock valued at $466,441,000 after buying an additional 257,670 shares during the last quarter. Institutional investors own 85.07% of the company’s stock.

Insider Activity

In other news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the business’s stock in a transaction dated Friday, November 7th. The stock was sold at an average price of $861.63, for a total transaction of $283,476.27. Following the completion of the transaction, the chief accounting officer owned 328 shares of the company’s stock, valued at approximately $282,614.64. The trade was a 50.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.08% of the company’s stock.

McKesson Stock Performance

McKesson stock opened at $869.44 on Tuesday. McKesson Corporation has a 52-week low of $558.13 and a 52-week high of $873.45. The firm has a 50 day moving average price of $791.80 and a two-hundred day moving average price of $736.10. The firm has a market cap of $107.31 billion, a price-to-earnings ratio of 34.67, a PEG ratio of 1.46 and a beta of 0.51.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, November 5th. The company reported $9.86 EPS for the quarter, beating the consensus estimate of $8.84 by $1.02. The company had revenue of $103.15 billion during the quarter, compared to the consensus estimate of $103.80 billion. McKesson had a negative return on equity of 196.66% and a net margin of 0.84%.The firm’s revenue for the quarter was up 10.2% compared to the same quarter last year. During the same period last year, the business posted $7.07 EPS. As a group, equities research analysts predict that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be paid a $0.82 dividend. The ex-dividend date is Monday, December 1st. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson’s dividend payout ratio is currently 10.21%.

Analyst Ratings Changes

Several research analysts have recently weighed in on MCK shares. Mizuho boosted their price objective on shares of McKesson from $750.00 to $770.00 and gave the stock a “neutral” rating in a research note on Wednesday, September 24th. Jefferies Financial Group boosted their price target on McKesson from $820.00 to $900.00 and gave the stock a “buy” rating in a research report on Monday, October 13th. Wells Fargo & Company upped their price objective on McKesson from $816.00 to $914.00 and gave the company an “equal weight” rating in a research note on Monday, November 10th. Zacks Research raised McKesson from a “hold” rating to a “strong-buy” rating in a research report on Monday, October 27th. Finally, Bank of America lifted their target price on McKesson from $800.00 to $850.00 and gave the stock a “buy” rating in a research note on Wednesday, September 24th. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $887.69.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.